Your session is about to expire
← Back to Search
Other
A novel digital health device for Neurodegenerative Disease
N/A
Waitlist Available
Led By Mandy Salomon, PhD
Research Sponsored by Mentia DTx
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
Study Summary
This trial will test how a new videogame can help people with no medical training to prepare for activities of daily living, which may reduce problems associated with those activities.
Eligible Conditions
- Neurodegenerative Disease
- Dementia
- Alzheimer's Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Alzheimer's Disease Cooperative Study Activities of Daily Living (ADCS-ADL- severe)
Dementia Quality of Life - Care Home (DemQol-CH)
The Neuropsychiatric Inventory - Nursing Home Version (NPI-NH) The minimum and maximum values are A higher score means a better or worse outcome.
Secondary outcome measures
Approaches to Dementia Questionnaire (ADQ)
Sense of Competence in Dementia Care Staff (SCIDS) scale
Trial Design
1Treatment groups
Experimental Treatment
Group I: Persons residing in long-term care homesExperimental Treatment1 Intervention
Subjects' ADLs are studied with intervention compared to baseline (without intervention).
Find a Location
Who is running the clinical trial?
Mentia DTxLead Sponsor
National Institute on Aging (NIA)NIH
1,669 Previous Clinical Trials
28,005,063 Total Patients Enrolled
Mandy Salomon, PhDPrincipal InvestigatorMentia DTx
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You do not currently experience pain.You have normal hearing or corrected hearing with the use of hearing aids.You have clear eyesight, or you wear glasses that correct your vision.You need to be able to understand either English or Russian.You might feel nervous or restless while doing daily activities.
Research Study Groups:
This trial has the following groups:- Group 1: Persons residing in long-term care homes
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are recruitments still open for this research project?
"As seen on clinicaltrials.gov, the current version of this trial is not actively seeking participants. Despite it being initially posted and last edited on June 9th and September 10th 2022 respectively, no new enrollments are available at present time; however, there are 798 other medical studies currently recruiting patients."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger